Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy

Samir E. Witta, Robert M. Jotte, Katrik Konduri, Marcus A. Neubauer, Alexander I. Spira, Robert L. Ruxer, Marileila Varella-Garcia, Paul A. Bunn, Fred R. Hirsch

Research output: Contribution to journal › Article › peer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences